EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.

Chinaranagari S, Sharma P, Chaudhary J. EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer. Oncotarget. 2014 Aug 30; 5(16):7172-82.

View in: PubMed

authors with profiles

Jaideep Chaudhary

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support